Nature Medicine: Biosimilars legislation awakens data exclusivity debate
Keyword(s): biologics, data exclusivity
Document Description / Abstract:
Nature Medicine news article providing a quick overview of the data exclusivity issues surrounding biologics, mentions AMSA as advocating for 5 years of data exclusivity.
This document has been marked "Restricted" and may not be downloaded without first logging in. Please contact UAEM in order to inquire about accessing this document
